Table: begin end state 1 11 non-cytoplasmic 12 30 transmembrane 31 62 cytoplasmic 63 86 transmembrane 87 89 non-cytoplasmic 90 111 transmembrane 112 138 cytoplasmic 139 158 transmembrane 159 176 non-cytoplasmic 177 195 transmembrane 196 201 cytoplasmic 202 225 transmembrane 226 230 non-cytoplasmic 231 256 transmembrane 257 293 cytoplasmic 294 317 transmembrane 318 323 non-cytoplasmic 324 341 transmembrane 342 352 non-cytoplasmic 353 374 transmembrane 375 386 cytoplasmic 387 408 transmembrane 409 413 non-cytoplasmic 414 440 transmembrane 441 495 cytoplasmic
Input: >202182 FitnessBrowser__MR1:202182 MNEIVNAVNNIVWSPALVYLCLGVGLFFSLRSRFLQLRHLPEMIRLMFDGKSTDAGVSSF QALAMTLAGRVGTGNIAGVATAITFGGPGALFWMWMVAFLGASSAFVESTLGQVYKEKIN GEYRGGPAFYIEKGLGMKWYAWTFAIATIFACGVLLPGVQANSIGASLKTAFDIDPNVTA AVLAMLLGFIIFGGVKRIANFATLVVPFMALGYIIVACVIIALNIDQLPGILWLIIKSAF GFDAGFGAILGLAIMWGVKRGVYSNEAGQGTGPHASSAAAVTHPAKQGLVQAFSVYIDTL FVCSATGFMLLITGLYNVQGPDGAALYTGIAGVAAGSGYVQTAMESMMPGFGNMFVAIAL FFFAFTTIVAYYYIAETNIAYINRKVNRPWLTVMLKVIIMASTVYGTVKTADLAWGMGDI GVGIMAWLNIIAIILLQKVAFTCLKDYESQQKQGIEPQFDPEKLGIPHADYWVERKNAQD EPMSIRHSIESKKRV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server